Beacon Bridge Wealth Partners’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,631
Closed -$342K 88
2025
Q1
$342K Buy
1,631
+22
+1% +$4.28K 0.15% 70
2024
Q4
$286K Hold
1,609
0.12% 75
2024
Q3
$318K Hold
1,609
0.14% 71
2024
Q2
$276K Sell
1,609
-350
-18% -$58K 0.13% 79
2024
Q1
$357K Sell
1,959
-650
-25% -$112K 0.17% 71
2023
Q4
$404K Sell
2,609
-112
-4% -$16.3K 0.2% 63
2023
Q3
$406K Sell
2,721
-171
-6% -$25.1K 0.21% 56
2023
Q2
$390K Sell
2,892
-19
-0.7% -$2.79K 0.2% 48
2023
Q1
$464K Buy
2,911
+283
+11% +$43.3K 0.28% 40
2022
Q4
$425K Buy
+2,628
New +$403K 0.31% 40

Other funds holding ABBV

Beacon Bridge Wealth Partners's ABBV Position: Q2 2025 in Review

Beacon Bridge Wealth Partners sold out of AbbVie (ABBV) in Q2 2025, closing a stake of 1,631 shares — an estimated $342K sold.

Beacon Bridge Wealth Partners first reported a position in ABBV in Q4 2022 and held it in 10 quarters. The position peaked at $464K in Q1 2023. 3,780 funds tracked by Wall St. Rank hold ABBV as of Q2 2025.

  • Beacon Bridge Wealth Partners reported no remaining AbbVie position as of Q2 2025 after selling out during the quarter.
  • Beacon Bridge Wealth Partners sold 1,631 AbbVie shares in Q2 2025, an estimated $342K.
  • Beacon Bridge Wealth Partners first reported a position in AbbVie in Q4 2022 and held it in 10 quarters.
  • Beacon Bridge Wealth Partners's AbbVie position peaked at $464K in Q1 2023.
  • 3,780 funds tracked by Wall St. Rank held AbbVie as of Q2 2025.

Based on Beacon Bridge Wealth Partners's 13F filing for Q2 2025, filed 24 Jul 2025.